Hims & Hers Launches Health Collective and Community Member Council
Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced two new programs dedicated to serving its customers in even more personalized ways, encouraging customers to play an active role in the decisions and choices that shape their healthcare experience.
Hims & Hers to Announce Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025
Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report fourth quarter and full year 2024 financial results after the market closes on Monday, February 24, 2025. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day.
The Shape of America 2024: Hims & Hers Shares an In-Depth Look Into How Americans Feel About Weight
For most Americans, weight is more than just a number. It shapes our health, our mood, our confidence, our spending, and the decisions we make in our day to day lives. In fact, 75% of us think about our weight every single day, and 14% say it’s constantly on our minds.
Hims & Hers Named to Inc.’s 2024 Best in Business List in Health Products Category
Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, is proud to announce its inclusion on the Inc. 2024 Best in Business list in the Health Products category. Inc.’s annual Best in Business Awards celebrate the exceptional achievements and contributions of companies that have made a profound impact on their industries and on society at large.
Hims & Hers Expands Nutrition Support to Fuel Customers’ Weight Loss Journeys
Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that Hims & Hers customers will now be able to supplement their treatment plan with daily meal replacement bars and shakes to support them on their comprehensive weight loss journey.
Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions
Hims & Hers Health, Inc. (“Hims & Hers”) (
NYSEHIMS), the leading health and wellness platform, today announced Deb Autor, former deputy commissioner at the FDA, will join the company’s board of directors, and Janet Stevens, a pharmaceutical quality expert, will join the company as Global Head of Quality & Safety. Hims & Hers continues to prioritize safety across its platform, offerings, and leadership so that every customer can have the confidence that the solutions they have access to are safe, high-quality, and personalized for their needs.
Americans Continue to Struggle to Access Branded GLP-1s as Shortages Continue
Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today shared more data on the challenges Americans are facing when trying to access branded GLP-1 medication and introduced a GLP-1 Supply Tracker, where individuals can be a part of advocating for better access to the medications they need.
Hims & Hers Health, Inc. Reports Third Quarter 2024 Financial Results
Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today announced financial results for the third quarter ended September 30, 2024 in a shareholder letter that is posted at investors.hims.com.
How Compounded Treatments Are Helping Hims & Hers Customers Meet Their Weight Loss Goals
Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today released a white paper entitled “Hims & Hers Weight Loss: A Look at Early Customer Experiences and Outcomes” which outlines how customers are achieving positive outcomes with compounded medications through our weight loss program. Early customer results indicate they are managing side effects well, staying on treatment, and overall feeling healthier.
Top 3 Stocks Institutions Are Buying Right NowDespite the stock market trading at new all-time highs, institutions still find enough reason to buy more enormous stakes in three stocks.
Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers
Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced Dr. Jessica Shepherd is joining as the first Chief Medical Officer of Hers. As the company invests further in personalized healthcare designed for women, Dr. Shepherd will guide the clinical expertise that forms the foundation of the Hers brand across sexual health, dermatology, weight loss, and mental health.
Hims & Hers to Announce Third Quarter 2024 Financial Results on November 4, 2024
Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today announced that it will report third quarter financial results after the market closes on Monday, November 4, 2024. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day.
Top 3 Stocks with Explosive Call Option Activity: What to WatchThree stocks reported a surge in call option buying recently, showing investors that there could be a path to more upside potential, analysts agree
Hims & Hers Stock Joins S&P 600: Is More Upside on the Horizon?There is now a new reason to look into Hims & Hers stock for additional upside, including the new addition to the S&P 600 index alongside double-digit growth.
Hims & Hers to Offer Access to Compounded GLP-1 Injections for as Low as $99/Month to U.S. Military, Veterans, Teachers, Nurses and First Responders
Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform committed to breaking down barriers to safe and affordable healthcare, today announced access to the most common compounded GLP-1 subscriptions for as low as $99 a month for eligible U.S. military, veterans, teachers, nurses and first responders.
Invest While You Can: Pullbacks on These 3 Stocks Won’t Last LongThree stocks stand out for investors to consider as they recently had big selloffs. There are fundamental reasons to believe that these discounts won't last
Top 3 Stocks to Watch: Options Traders Bet on Big GainsThree stocks have stood out for call option traders to bet on in the coming months as a view for a recovery rally after an S&P 500 sell-off last week
MarketBeat Week in Review – 8/5 - 8/9Stocks were looking for direction to end the week, but next week may bring more volatility with the latest reading on inflation and the start of retail earnings
Hims & Hers Reports Stellar Quarter: Stock Set for a RallyHims & Hers stock is showing the market why its fair value is double-digits above where it trades today, with Wall Street analysts to agree
Hims & Hers Health, Inc. Reports Second Quarter 2024 Financial Results
Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today announced financial results for the second quarter ended June 30, 2024 in a shareholder letter that is posted at investors.hims.com.
Hims & Hers Stock Falls on DexCom Fears: Analysts Predict RallyHims & Hers stock is looking like a worthy dip to watch in the coming months, especially as its decline had nothing to do with company operations
Can the New CEO Revive This Struggling Telehealth Stock?Virtual healthcare provider Teladoc Health Inc. (
NYSETDOC) stock is trading down 57.8% year-to-date (YTD). The collapse occurred after reporting Q4 2023
Pharmaceutical Industry Chief Kåre Schultz Joins Hims & Hers Board
Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced the appointment of Kåre Schultz to the company’s Board of Directors.
Is This Telehealth Stock a Buy After the Recent Pullback?Hims & Hers Health leverages telehealth's accessibility to disrupt traditional healthcare and deliver personalized wellness solutions.
Hims & Hers to Announce Second Quarter 2024 Financial Results on August 5, 2024
Hims & Hers Health, Inc. ("Hims & Hers") (
NYSEHIMS), the leading health and wellness platform, today announced that it will report second quarter financial results after the market closes on Monday, August 5, 2024. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day.
